Language selection

Search

Patent 2353680 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2353680
(54) English Title: PROCESS FOR THE PRODUCTION OF CYCLENE
(54) French Title: PROCEDE DE PREPARATION DE CYCLENE
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07D 257/02 (2006.01)
(72) Inventors :
  • PLATZEK, JOHANNES (Germany)
  • HOYER, KARSTEN (Germany)
  • GRASKE, KLAUS-DIETER (Germany)
  • RADUCHEL, BERND (Germany)
(73) Owners :
  • BAYER INTELLECTUAL PROPERTY GMBH (Not Available)
(71) Applicants :
  • SCHERING AKTIENGESELLSCHAFT (Germany)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued: 2008-09-09
(86) PCT Filing Date: 1999-11-17
(87) Open to Public Inspection: 2000-06-08
Examination requested: 2004-10-25
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/EP1999/009089
(87) International Publication Number: WO2000/032581
(85) National Entry: 2001-05-30

(30) Application Priority Data:
Application No. Country/Territory Date
198 56 481.3 Germany 1998-12-02

Abstracts

English Abstract





The invention relates to a novel one-pot method of producing cyclene.


French Abstract

L'invention concerne un nouveau procédé à récipient unique de préparation de cyclène.

Claims

Note: Claims are shown in the official language in which they were submitted.





20

The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:

1. A process for the production of cyclene


Image

in a single-pot, the process comprising the steps of:
reacting triethylenetetramine with 40% glyoxal at 20°C to
80°C in a first polar protic solvent for 4 to 40 hours to
yield an intermediate tricyclic compound;
removing the first polar protic solvent and alkylating
the intermediate tricyclic compound at the two secondary
amine nitrogens with a 1,2-difunctionalized alkylating
agent X(CH2)2X in a condensation reaction, wherein X is a
nucleofuge group, in a polar aprotic solvent, at 20°C to
120°C for 2 to 24 hours to yield a condensation product;
removing the polar aprotic solvent and treating the
condensation product with hydrazine hydrate in a second
polar protic solvent at a pH of 3 to 6 for 12 to 48 hours
at reflux temperature to yield a cyclene salt solution;
adding a base to the cyclene salt solution to release
cyclene and yield a reaction solution;
evaporating the reaction solution to a dry state to yield
a reaction product; and
isolating cyclene from the reaction product.




21

2. A process according to claim 1, wherein the
intermediate tricyclic compound is alkylated in the
presence of an auxiliary base.


3. A process according to claim 2, wherein the auxiliary
base comprises sodium carbonate, potassium carbonate,
calcium carbonate, sodium bicarbonate, potassium hydrogen
carbonate, magnesium carbonate, magnesium hydrogen
carbonate, lithium hydroxide or lithium carbonate.


4. A process according to claim 1, 2 or 3, wherein the
first and second polar protic solvents each comprise
methanol, ethanol, isopropanol, butanol, glycol, water or
mixtures thereof.


5. A process according to claim 4, wherein the first and
second polar protic'solvents each comprise ethanol.


6. A process according to any one of claims 1 to 5,
wherein the polar aprotic solvent comprises N,N-
dimethylformamide (DMF), N,N-dimethylacetamide (DMAC), N-
methylpyrrolidone (NMP), tetramethylurea, formamide or
dimethylpropylene urea (DMPU).


7. A process according to claim 6, wherein the polar
aprotic solvent comprises N,N-dimethylformamide (DMF).

8. A process according to any one of claims 1 to 7,
wherein the alkylating agent X(CH2)2X comprises 1,2-
dibromoethane, 1,2-dichloroethane, 1,2-ditosylethane, 1,2-
dimesylethane or 1,2-diiodoethane.




22

9. A process according to claim 8, wherein the alkylating
agent X(CH2)2X comprises 1,2-dichloroethane.


10. A process according to any one of claims 1 to 9,
wherein the base used to release cyclene comprises sodium
hydroxide, potassium hydroxide, calcium hydroxide or a
basic ion exchanger.


11. A process according to claim 10, wherein the base used
to release cyclene comprises sodium hydroxide or potassium
hydroxide.


12. A process according to any one of claims 1 to 11,
wherein the reaction of triethylenetetramine with glyoxal
is performed at 20°C to 40°C for 15 to 20 hours.


13. A process according to any one of claims 1 to 12,
wherein the condensation reaction is performed with the
1,2-difunctionalized alkylating agent X(CH2)2X at 30°C to
70°C for 6 to 10 hours.


14. A process according to any one of claims 1 to 13,
wherein the condensation product is treated with hydrazine
hydrate is performed for 25 to 35 hours.


15. A process according to any one of claims 1 to 14,
wherein the step of isolating cyclene comprises treating
the reaction product with toluene, trifluoro-methylbenzene
or diethoxymethane.


16. A process according to any one of claims 1 to 15,
wherein the step of isolating cyclene comprises mixing the




23

reaction product with activated carbon and formaldehyde
diethylacetal.


17. A process according to any one of claims 1 to 16,
wherein the condensation product is treated with hydrazine
hydrate in the second polar protic solvent at a pH of 3 to
4.


18. A process according to any one of claims 1 to 17,
wherein the reaction of triethylenetetramine with glyoxal
is performed at 20°C to 40°C for 15 to 20 hours.

Description

Note: Descriptions are shown in the official language in which they were submitted.



CA 02353680 2007-12-13

1
Process for the Production of Cyclene

The invention relates to the subject that is characterized
in the claims, i.e., a new process for the production of cyclene.
Cyclene (1,4,7,10-tetraazacyclododecane) is a frequently

used starting material in the production of macrocyclic
complexing agents and is mainly used in the area of nuclear
resonance tomography as a ligand for.gadolinium. Two
preparations are already commercially available with ProHance(R)
of Bristol-Myers-Squibb and Dotarem(R) of Guerbet. Special
research and development projects also use cyclene as a starting
material. There is therefore a need for an easy and economical
process for the production of this educt.

One of the first published processes (Richman and Atkins, J.
Am. Chem. Soc. 1974, 96, p. 2268) employs the cyclization of a
sodium bis-sulfonamide with a corresponding functionalized
diethylene sulfonamide. In their synthesis, Weisman and Reed (J.
Org. Chem. 1996, 61, pp. 5186-5187) use the reaction of a bis-
thioimidoester with triethylenetetramine for the creation of a
tricyclic bis-imine, which is ultimately hydrolyzed to cyclene
after reduction.

The processes of V. Panetta et al. (Tetrahedron Lett. 1992,
Vol. 33, No. 38, pp. 5505-5508), which perform a cyclization of a
tetra-trifluoromethanesulfonic acid amide of triethylenetetramine
with 1,2-dibromoethane, follow a more indirect approach to


CA 02353680 2001-05-30
2
cyclene. The last reaction step comprises the release of
cyclene. The process of the Nycomed Company (WO 96/28433) after
the production of tribenzylcyclene is also dependent on such a
procedure. The synthesis is accomplished by the reaction of a
suitable triamine with a monoamine or the two suitable diamines.
The process that is disclosed in DE 19608307 and that contains a
tetramerization of N-benzylaziridine as a key step also results
in tetrabenzylcyclene.

As described in WO 97/31005 and US 5,587,451, the Dow
Chemical Company uses a bis-imidazoline that starts from
triethylenetetramine as an intermediate product. The rings in
the tetracyclic intermediate product are closed with 1,2-
dibromoethane. The subsequent hydrolysis releases the cyclene.

As described in WO 97/49691, the Bracco Company uses a
direct approach to cyclene, which starts with the condensation of
triethylenetetramine with glyoxal -- which was already disclosed
by Weisman et al. (Tetrahedron Lett. 1980, Vol. 21, pp. 335-338).
Then, the latter is converted into a tetracyclic intermediate

compound by reaction with 1,2-dibromoethane. The removal of the
ethylene bridge that connects the four heteroatoms is carried out
by oxidation with bromine with subsequent hydrolysis (or else by
hydrolysis with a primary diamine, WO 98/49151). The total yield
is indicated with 25%.


CA 02353680 2001-05-30
3
H H 1) Ca(OH)2 / H20 F7 BrCH2CH2Br
' n' 2) Glyoxal Na2C03 / DMAC N N

C 3h 75% ENXN 80 C 6h 45% CNXN
NHZ NH2 N N L-/
H H

Br2 / H20 + 2Br NaOH / H20 n
H H
pH 4.5 N pH 14 N N
25 C 18h CN
N!'185*C N15 bar EN N
~ + 5h 68% H' U 'H
Diagram 1: Synthesis Sequence of the Bracco Company (WO
97/49691)

The synthesis that is disclosed in WO 96/28432 of the
Nycomed Company resembles the above-described synthesis, with the
decisive difference being the hydrolysis of the central ethylene
bridge. Here, the reaction is achieved by addition of
hydroxylamine in an ethanolic solution while being heated. The
total yield for this reaction sequence is approximately 45%.

BrCH2CH2Br / 17
H __ H Glyoxal/
'N N' EtOH N N DMF N,,~ N
NHZ NH2 E ~ 20 C 20h 75% CN ~ N ~ 20 C 20h 70% o N" ND
1 r
H H ~_J


CA 02353680 2001-05-30
4
NH2OH' HCI H\ n ~H
EtOH IN N N~
90 C 18h N
H~ U 'H

Diagram 2: Synthesis Sequence of the Nycomed Company (WO
96/28432)
Evaluation of the Process:

The process according to WO 97/49691, supported by
experimental reworking, has some decisive drawbacks, which are
summarized briefly below:

The production of the tricyclic compound cannot be
reproduced as described, since:

-- The calcium hydroxide cannot be quantitatively separated.
-- Larger amounts of water must be distilled off.

-- The product does not accumulate as an oil, as indicated.
The purification of the tetracyclic compound is very
expensive:

-- The extraction of the product from a solid reduces the
yield.

Hydrolysis into cyclene has proven to be very difficult:

-- An autoclave reaction must be performed at pH = 14 and at
185 C.

-- The product crystallizes poorly and with heavy
contamination from the reaction solution.


CA 02353680 2001-05-30
The process according to WO 96/28432 also gives rise to
criticism. The basic drawbacks are listed below:

-- All synthesis stages have long stirring times.

-- The purification of the tetracyclic compound is carried
out via a preparative column chromatography.

-- The hydrolysis to cyclene lasts for a very long time,
and the indicated purification method does not yield
the product in the desired purity.

All other processes comprise multistage synthesis sequences,
in which intermediate products are isolated, which generally is
time-consuming and raw material-intensive. The process of
Weismann and Reed is ruled out for commercial synthesis, since it
is dependent on dithiooxamide (about DM 400/100 g) as one of the
starting materials. In the process of Richman and Atkins as well
as V. Panetta et al., correspondingly protected amines must first
be prepared. After the reaction has been completed, as also in
the process of the Dow Chemical Company, Nycomed (WO 96/28433)
and Schering (DE19608307), the cleavage of these protective
groups is necessary as an additional reaction step, which
produces a poorer material balance relative to the desired
product. In the case of tetramerization of benzylaziridine, it
is necessary to work with large amounts of carcinogenic
substances.

A profitable process should use raw materials that are as
reasonably priced, as environmentally safe and as easily
accessible as possible. The reaction times should also be short
and should occur with little energy use. Moreover, the amounts


CA 02353680 2001-05-30
6
of material during the overall synthesis should be as small as
possible.

This object is achieved by this invention.

It has been found that a process for the production of
cyclene

H H
N N-
N N
H H
characterized in that in a single-pot process,
triethylenetetramine is reacted with 40% glyoxal at 20 C to 80 C
in a polar, protic solvent, preferably methanol, ethanol,
isopropanol, butanol, glycol, water or mixtures thereof,
especially preferably ethanol, within 4 to 40 hours, preferably
15 to 20 hours; after the solvent has been removed, the
intermediate tricyclic compound that is thus formed is alkylated
to the two secondary amine-nitrogens with a 1,2-difuntionalized
alkylating agent X(CHz)2X, in which X stands for a nucleofuge
group, preferably with 1,2-dibromoethane, 1,2-dichloroethane,
1,2-ditosylethane, 1,2-dimesylethane or 1,2-diiodoethane,
especially preferably with 1,2-dichloroethane in a polar aprotic
solvent, preferably in N,N-dimethylformamide (DMF), N,N-
dimethylacetamide (DMAC), N-methylpyrrolidone (NMP), tetramethyl
urea, formamide or dimethylpropylene urea (DMPU), especially
preferably in DMF, optionally in the presence of an auxiliary


CA 02353680 2001-05-30
7
base, preferably sodium carbonate, potassium carbonate, calcium
carbonate, sodium bicarbonate, potassium hydrogen carbonate,
magnesium carbonate, magnesium hydrogen carbonate, lithium
hydroxide or lithium carbonate, especially preferably without an
auxiliary base, at 20 to 120 C, preferably 30 to 70 C, within 2

to 24 hours, preferably 6 to 10 hours; after the solvent has been
removed, the thus obtained condensation product is treated with
hydrazine hydrate in a polar protic solvent, preferably methanol,
ethanol, isopropanol, butanol, glycol, water and/or mixtures
thereof, especially preferably ethanol, at a pH of 3 to 6,
preferably 3 to 4, 12 to 48 hours, preferably 25 to 35 hours, at
reflux temperature; then the cyclene is released from the cyclene
salt by adding a base, preferably sodium hydroxide, potassium
hydroxide, calcium hydroxide or a basic ion exchanger, especially
preferably sodium hydroxide and potassium hydroxide, and after
the reaction solution is evaporated to the dry state, it is
isolated,

surprisingly enough achieves the above-mentioned object.

The isolation of the cyclene is preferably carried out by
crystallization from toluene, trifluoromethylbenzene or
diethoxymethane, whereby the latter is especially preferred.

By way of example, diagram 3 again sheds light on the


CA 02353680 2001-05-30
8
process of the synthesis according to the invention:
1) Giyoxal /EtOH
20 C 20h
H H 2) CICHZCH2C1 /DMF H H
40 C 8h
N N__ N N
3) HzN-NH2' H20 ~
NHZ NHZ pH 4/ HCI N N
TETA Reflux 30h H ~-- ~ H
4) KOH
pH13
5) DEM
50 - 65% von TETA
[Key:]

von = of

Advantages of the Process:

The process for the production of cyclene according to the
invention has considerable advantages relative to the previous
processes due to its design as a single-pot process.

-- No time-intensive and raw material-intensive isolating
steps of the intermediate products are necessary.


CA 02353680 2001-05-30
9
-- The reaction with amine is carried out without
generating considerable amounts of by-products.

-- The raw materials are reasonably priced and easily
accessible.

-- Few wastes accumulate.

-- The total synthesis time is short.

-- A new, economical purification process for cyclene is
used.

-- The yield is higher than in the process of the prior
art.

The following example is used for a more detailed
explanation of the subject of the invention.


CA 02353680 2001-05-30
Example 1

1,4,7,10 Tetraazacyclododecane (= cyclene):

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of ethanol and mixed with 39 ml of 40% glyoxal in water (0.342
mol) at room temperature. After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil,
which is taken up in 400 ml of dimethylformamide and mixed with
81.2 ml (101.5 g = 1.026 mol) of 1,2-dichloroethane, is obtained.
After 8 hours of stirring at 40 C, it is concentrated by
evaporation in a vacuum, the residue is taken up in 400 ml of
ethanol and acidified to about pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature,
and it is heated under reflux for 30 hours. The reaction
solution is set at pH = 13 with solid potassium hydroxide. The
reaction solution is subsequently concentrated by evaporation in
a vacuum, taken up once more in 100 ml of ethanol, and the
solvent is removed. The residue is mixed with 25 g of activated
carbon and 100 ml of formaldehyde diethylacetal, and it is heated
under reflux for some time before the hot solution is filtered
through a membrane. After the solution is cooled, the product is
isolated by filtration. 38.3 g of cyclene (0.222 mol = 65% of
theory) is obtained as a crystalline solid.


CA 02353680 2001-05-30
11
Example 2

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of ethanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of
dimethylformamide and mixed with 88.5 ml (192.8 g = 1.026 mol) of
1,2-dibromoethane. After 6 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature,
and it is heated under reflux for 30 hours. The reaction
solution is set at pH = 13 with solid potassium hydroxide. The
reaction solution is subsequently concentrated by evaporation in
a vacuum, taken up once more in 100 ml of ethanol, and the
solvent is removed again in a vacuum. The residue is mixed with
25 g of activated carbon and 150 ml of formaldehyde
diethylacetal, and it is heated under reflux for some time before
the hot solution is filtered through a membrane. After the
solution is cooled, the product is isolated by filtration.

39.5 g of cyclene (67% of theory) is obtained as a crystalline
solid.


CA 02353680 2001-05-30
12
Example 3

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of ethanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which is then taken up in 400 ml of
dimethylformamide and is mixed with 82.6 ml (274.8 g = 1.026 mol)
of 1,2-diiodoethane. After 5 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature,
and it is heated under reflux for 30 hours. The reaction
solution is set at pH = 13 with solid potassium hydroxide. The
reaction solution is subsequently concentrated by evaporation in
a vacuum, taken up once more in 100 ml of ethanol, and the
solvent is removed again in a vacuum. The residue is mixed with
25 g of activated carbon and 150 ml of formaldehyde
diethylacetal, and it is heated under reflux for some time before
the hot solution is filtered through a membrane. After the
solution is cooled, the product is isolated by filtration.

37.1 g of cyclene (63% of theory) is obtained as a crystalline
solid.


CA 02353680 2001-05-30
13
Example 4

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in i
ml of methanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of

dimethylformamide and mixed with 81.2 ml (101.5 g = 1.026 mol) of
1,2-dichloroethane. After 8 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature,
and it is heated under reflux for 30 hours. The reaction
solution is set at pH = 13 with solid potassium hydroxide. The
reaction solution is subsequently concentrated by evaporation in
a vacuum, taken up once more in 100 ml of ethanol, and the
solvent is removed again in a vacuum. The residue is mixed with
25 g of activated carbon and 150 ml of formaldehyde
diethylacetal, and it is heated under reflux for some time before
the hot solution is filtered through a membrane. After the
solution is cooled, the product is isolated by filtration.

37.7 g of cyclene (64% of theory) is obtained as a crystalline
solid.


CA 02353680 2001-05-30
14
Example 5

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of ethanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of dimethyl
acetamide and is mixed with 81.2 ml (101.5 g= 1.026 mol) of 1,2-
dichloroethane. After 8 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature
and heated under reflux for 30 hours. The reaction solution is
set at pH = 13 with solid potassium hydroxide. The reaction
solution is subsequently concentrated by evaporation in a vacuum,
taken up once more in 100 ml of ethanol, and the solvent is
removed again in a vacuum. The residue is mixed with 25 g of
activated carbon and 150 ml of formaldehyde diethylacetal and
heated under reflux for some time before the hot solution is
filtered through a membrane. After the solution is cooled, the
product is isolated by filtration. 37.7 g of cyclene (64% of
theory) is obtained as a crystalline solid.


CA 02353680 2001-05-30
Example 6

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of ethanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of tetramethylurea
and mixed with 81.2 ml (101.5 g = 1.026 mol) of 1,2-
dichloroethane. After 8 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature
and heated under reflux for 30 hours. The reaction solution is
set at pH = 13 with solid potassium hydroxide. The reaction
solution is subsequently concentrated by evaporation in a vacuum,
taken up once more in 100 ml of ethanol, and the solvent is.again
removed in a vacuum. The residue is mixed with 25 g of activated
carbon and 150 ml of formaldehyde diethylacetal, and it is heated
under reflux for some time before the hot solution is filtered
through a membrane. After the solution is cooled, the product is
isolated by filtration. 37.1 g of cyclene (63% of theory) is
obtained as a crystalline solid.


CA 02353680 2001-05-30
16
Example 7

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of ethanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of tetramethylurea
and mixed with 88.5 ml (192.8 g = 1.026 mol) of 1,2-
dibromoethane. After 6 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature
and heated under reflux for 30 hours. The reaction solution is
set at pH = 13 with solid potassium hydroxide. The reaction
solution is subsequently concentrated by evaporation in a vacuum,
taken up once more in 100 ml of ethanol, and the solvent is
removed again in a vacuum. The residue is mixed with 25 g of
activated carbon and 150 ml of formaldehyde diethylacetal and
heated under reflux for some time before the hot solution is
filtered through a membrane. After the solution is cooled, the
product is isolated by filtration. 37.6 g of cyclene (64%
measured) is obtained as a crystalline solid.


CA 02353680 2001-05-30
17
Example 8

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of methanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of
dimethylformamide and mixed with 88.5 ml (192.8 g = 1.026 mol) of
1,2-dibromoethane. After 6 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution and heated under
reflux for 30 hours. The reaction solution is set at pH = 13
with solid potassium hydroxide. The reaction solution is
subsequently concentrated by evaporation in a vacuum, taken up
once more in 100 ml of ethanol, and the solvent is removed again
in a vacuum. The residue is mixed with 25 g of activated carbon
and 150 ml of formaldehyde diethylacetal and heated under reflux
for some time before the hot solution is filtered through a
membrane. After the solution is cooled, the product is isolated
by filtration. 35.9 g of cyclene (61% of theory) is obtained as
a crystalline solid.


CA 02353680 2001-05-30
18
Example 9

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of ethanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of
dimethylformamide and mixed with 81.2 ml (101.5 g = 1.026 mol) of
1,2-dichloroethane. After 8 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added at room temperature to this reaction solution,
and then it is heated under reflux for 30 hours. The reaction
solution is set at pH = 13 with solid potassium hydroxide. The
reaction solution is subsequently concentrated by evaporation in
a vacuum, taken up once more in 100 ml of ethanol, and the
solvent is removed again in a vacuum. The residue is mixed with
25 g of activated carbon and 200 ml of toluene and heated under
reflux for some time before the hot solution is filtered through
a membrane. After the solution is cooled, the product is
isolated by filtration. 35.8 g of cyclene (61% of theory) is
obtained as a crystalline solid.


CA 02353680 2001-05-30
19
Example 10

1,4,7,10-Tetraazacyclododecane (= cyclene)

50 g of triethylenetetramine (0.342 mol) is dissolved in 1 1
of 2-propanol and mixed at room temperature with 39 ml of 40%
glyoxal in water (0.342 mol). After 20 hours of stirring, the
solvent is distilled off in a vacuum, and an orange-colored oil
is obtained, which then is taken up in 400 ml of
dimethylformamide and mixed with 81.2 ml (101.5 g = 1.026 mol) of
1,2-dichloroethane. After 8 hours of stirring at 40 C, it is
concentrated by evaporation in a vacuum, the residue is taken up
in 400 ml of ethanol and acidified to pH = 3-4 with 37% aqueous
hydrochloric acid. 166 ml (171 g = 3.42 mol) of hydrazine
hydrate is added to this reaction solution at room temperature
and heated under reflux for 30 hours. The reaction solution is
set at pH = 13 with solid potassium hydroxide. The reaction
solution is subsequently concentrated by evaporation in a vacuum,
taken up once more in 100 ml of ethanol, and the solvent is
removed again in a vacuum. The residue is mixed with 25 g of
activated carbon and 150 ml of formaldehyde diethylacetal and
heated under reflux for some time before the hot solution is
filtered through a membrane. After the solution is cooled, the
product is isolated by filtration. 37.2 g of cyclene (63% of
theory) is obtained as a crystalline solid.

Representative Drawing

Sorry, the representative drawing for patent document number 2353680 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2008-09-09
(86) PCT Filing Date 1999-11-17
(87) PCT Publication Date 2000-06-08
(85) National Entry 2001-05-30
Examination Requested 2004-10-25
(45) Issued 2008-09-09
Deemed Expired 2015-11-17

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $300.00 2001-05-30
Maintenance Fee - Application - New Act 2 2001-11-19 $100.00 2001-05-30
Registration of a document - section 124 $100.00 2002-04-25
Maintenance Fee - Application - New Act 3 2002-11-18 $100.00 2002-11-04
Maintenance Fee - Application - New Act 4 2003-11-17 $100.00 2003-10-23
Maintenance Fee - Application - New Act 5 2004-11-17 $200.00 2004-10-22
Request for Examination $800.00 2004-10-25
Maintenance Fee - Application - New Act 6 2005-11-17 $200.00 2005-10-24
Maintenance Fee - Application - New Act 7 2006-11-17 $200.00 2006-10-25
Maintenance Fee - Application - New Act 8 2007-11-19 $200.00 2007-10-19
Registration of a document - section 124 $100.00 2008-06-18
Final Fee $300.00 2008-06-18
Maintenance Fee - Patent - New Act 9 2008-11-17 $200.00 2008-10-17
Maintenance Fee - Patent - New Act 10 2009-11-17 $250.00 2009-11-05
Maintenance Fee - Patent - New Act 11 2010-11-17 $250.00 2010-11-04
Maintenance Fee - Patent - New Act 12 2011-11-17 $250.00 2011-11-04
Maintenance Fee - Patent - New Act 13 2012-11-19 $250.00 2012-10-16
Registration of a document - section 124 $100.00 2013-06-17
Maintenance Fee - Patent - New Act 14 2013-11-18 $250.00 2013-10-22
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BAYER INTELLECTUAL PROPERTY GMBH
Past Owners on Record
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
GRASKE, KLAUS-DIETER
HOYER, KARSTEN
PLATZEK, JOHANNES
RADUCHEL, BERND
SCHERING AKTIENGESELLSCHAFT
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2001-05-30 1 5
Description 2001-05-30 19 620
Claims 2001-05-30 3 77
Cover Page 2001-09-24 1 23
Description 2007-12-13 19 616
Claims 2006-02-06 4 114
Cover Page 2008-08-26 1 24
Correspondence 2001-08-21 1 24
Assignment 2001-05-30 2 102
PCT 2001-05-30 9 295
PCT 2001-05-31 6 201
Assignment 2002-04-25 3 75
Prosecution-Amendment 2004-10-25 1 30
Correspondence 2007-11-08 1 24
Correspondence 2007-12-13 2 64
Prosecution-Amendment 2006-02-06 5 158
Correspondence 2008-01-14 1 73
Assignment 2008-06-18 5 200
Correspondence 2008-06-18 1 48
Assignment 2013-06-17 8 210